The American network “CNN” said that the US Food and Drug Administration “FDA” has approved a new home test to collect samples from people to detect corona virus.

According to the news, the new examination allows patients to collect their samples at home using the nasal smear test, then they send the sample via mail to Lab Corp laboratories, which developed this test.

The US Food and Drug Administration said home test kits will be available to consumers in most states in the coming weeks.

“Throughout the outbreak of this epidemic, we have facilitated test development to ensure patients have access to an accurate diagnosis, which includes supporting the development of reliable and accurate sample collection options at home,” said Food and Drug Administration Commissioner Dr. Stephen Han.

“The FDA’s work around the clock since the outbreak began led to the authorization and licensing of more than 50 diagnostic tests and interactions with more than 350 test developers,” Han added.

He pointed out that the US Food and Drug Administration coordinated and worked with Lab Corp laboratories to ensure that data taken from patient samples at home are safe and accurate, just like collecting samples that are in clinics or hospitals, adding: “With this procedure, there is now A convenient and reliable option for safe and comfortable collection of patient samples in their homes. “

The US Food and Drug Administration said in its statement: “It is important to note that this is not a general mandate to collect samples from patients at home using swabs, media, or other tests, or for tests that are performed entirely at home.”

The network pointed out that the new test includes a Q-tip nose swab, and its initial price is $ 119, according to the company website.

“We designed this home test to be easier and safer for healthcare workers and first responders during this difficult time,” Adam Schechter, CEO of LabCorp Labs.